Savara SVRA
NASDAQ SVRA
$4.99 +0.07 (+1.42%)
At close: Nov 11, 2026 · 4:00 PM EST

Savara (SVRA) Return on Equity [ROE] (2009 - 2026)

Updated

Savara's Return on Equity [ROE] was -89.85% in Q2 2026, down 3.68 percentage points from -86.17% a year earlier and down 19.12 percentage points from the prior quarter.

Analysis

Savara (SVRA) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Savara came in at -65.97%, up 0.22 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of -6.60 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -66.19% in FY2024 (-17.83 pp), -48.36% in FY2023 (-17.57 pp), -30.79% in FY2022 (+8.92 pp) and -39.71% in FY2021 (+19.66 pp).
  • Quarterly Return on Equity [ROE] has moved between -111.24% (Q3 2025) and -27.35% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has declined for 17 straight quarters, with an average year-over-year change of -17.93 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 56.57 percentage points); the worst was Q3 2025 (a drop of 53.10 percentage points).
  • Per Business Quant data, SVRA's Return on Equity [ROE] in the three quarters before Q2 2026 was -70.74% (Q1 2026), -81.85% (Q4 2025) and -111.24% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Savara 1.09 Bn 407.27 Mn - -121.97%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -121.97%
Jun 30, 2026 -87.35%
Mar 31, 2026 -68.19%
Dec 31, 2025 -79.44%
Sep 30, 2025 -108.06%
Jun 30, 2025 -81.74%
Mar 31, 2025 -63.93%
Dec 31, 2024 -51.97%
Sep 30, 2024 -54.27%
Jun 30, 2024 -67.58%
Mar 31, 2024 -49.40%
Dec 31, 2023 -37.90%
Sep 30, 2023 -41.18%
Jun 30, 2023 -45.48%
Mar 31, 2023 -39.39%
Dec 31, 2022 -34.56%
Sep 30, 2022 -33.71%
Jun 30, 2022 -31.06%
Mar 31, 2022 -29.81%
Dec 31, 2021 -29.33%
API Access

Savara Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SVRA&period=max&api_key=YOUR_API_KEY